Thrombotic Microangiopathies
"Thrombotic Microangiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
Descriptor ID |
D057049
|
MeSH Number(s) |
C15.378.140.855.925
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thrombotic Microangiopathies".
Below are MeSH descriptors whose meaning is more specific than "Thrombotic Microangiopathies".
This graph shows the total number of publications written about "Thrombotic Microangiopathies" by people in this website by year, and whether "Thrombotic Microangiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2017 | 5 | 1 | 6 |
2018 | 9 | 0 | 9 |
2019 | 1 | 1 | 2 |
2020 | 13 | 5 | 18 |
2021 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Thrombotic Microangiopathies" by people in Profiles.
-
Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e237-e240.
-
Thrombotic Microangiopathy, Antibody-Mediated Rejection, and Posterior Reversible Leukoencephalopathy Syndrome in a Liver Transplant Recipient: Interplay Between COVID-19 and Its Treatment Modalities. Exp Clin Transplant. 2021 Sep; 19(9):990-993.
-
Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy. Front Immunol. 2021; 12:680567.
-
Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic. J Intern Med. 2021 09; 290(3):655-665.
-
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies? Crit Rev Oncol Hematol. 2021 Jun; 162:103347.
-
COVID-19 and thrombotic microangiopathies. Thromb Res. 2021 06; 202:191-198.
-
Genetic justification of severe COVID-19 using a rigorous algorithm. Clin Immunol. 2021 05; 226:108726.
-
Renal Morphology in Coronavirus Disease: A Literature Review. Medicina (Kaunas). 2021 Mar 11; 57(3).
-
The Impact of COVID-19 on Vascular Surgery Practice: A Systematic Review. Vasc Endovascular Surg. 2021 Aug; 55(6):601-611.
-
Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies. Front Immunol. 2020; 11:604759.